Imperial College London

ProfessorSimakAli

Faculty of MedicineDepartment of Surgery & Cancer

Professor of Molecular Endocrine Oncology
 
 
 
//

Contact

 

+44 (0)20 7594 2811simak.ali

 
 
//

Location

 

133ICTEM buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Asaduzzaman:2018:10.1007/s10549-017-4633-6,
author = {Asaduzzaman, M and Constantinou, S and Min, H and Gallon, J and Lin, M-L and Singh, P and Raguz, S and Ali, S and Shousha, S and Charles, Coombes R and Lam, EW-F and Hu, Y and Yagüe, E},
doi = {10.1007/s10549-017-4633-6},
journal = {Breast Cancer Research and Treatment},
pages = {605--606},
title = {Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer},
url = {http://dx.doi.org/10.1007/s10549-017-4633-6},
volume = {167},
year = {2018}
}

RIS format (EndNote, RefMan)

TY  - JOUR
AB - In the original publication, Fig. 1 depicting the blot for EP300 in CAL51 cells (Fig. 1c) was unintentionally duplicated with that from MDA-MB-231 cells (Fig. 1d). The new figure given in this erratum depicts the correct EP300 blot in Fig. 1c.
AU - Asaduzzaman,M
AU - Constantinou,S
AU - Min,H
AU - Gallon,J
AU - Lin,M-L
AU - Singh,P
AU - Raguz,S
AU - Ali,S
AU - Shousha,S
AU - Charles,Coombes R
AU - Lam,EW-F
AU - Hu,Y
AU - Yagüe,E
DO - 10.1007/s10549-017-4633-6
EP - 606
PY - 2018///
SN - 0167-6806
SP - 605
TI - Correction to: Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer
T2 - Breast Cancer Research and Treatment
UR - http://dx.doi.org/10.1007/s10549-017-4633-6
UR - http://hdl.handle.net/10044/1/57000
VL - 167
ER -